WooGene B&G Co., Ltd (KOSDAQ: 018620)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,063.00
-12.00 (-1.12%)
Oct 8, 2024, 11:02 AM KST
-13.08%
Market Cap 30.39B
Revenue (ttm) 59.96B
Net Income (ttm) 166.93M
Shares Out 28.89M
EPS (ttm) 5.70
PE Ratio 184.53
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,010
Open 1,075.00
Previous Close 1,075.00
Day's Range 1,063.00 - 1,075.00
52-Week Range 962.00 - 1,590.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 13, 2024

About WooGene B&G

WooGene B&G Co., Ltd. engages veterinary medicines, microbial technology, and vaccines business in South Korea and internationally. It offers antibiotic, vaccine, nutrient, anti-inflammation, metabolic stimulant, and iron supplement products for swine, poultry, cattle, aquatic animals, companion animals, and raw materials, as well as operates vaccine research center. The company was formerly known as WooJin Co., Ltd. and changed its name to WooGene B&G Co., Ltd. in March 2001. WooGene B&G Co., Ltd. was founded in 1977 and is headquartered in Hw... [Read more]

Industry Pharmaceutical Preparations
Founded 1977
Employees 92
Stock Exchange KOSDAQ
Ticker Symbol 018620
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.